MedPath

Medical and economic implications of free bioprosthesis in aortic valve positio

Phase 4
Recruiting
Conditions
I35.0
Aortic (valve) stenosis
Registration Number
DRKS00011049
Lead Sponsor
Klinik für Herz-, Thorax- und Gefäßchirurgie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Operation worthy aortic stenosis associated with coronary heart disease, which requires the installation of at least one IMA graft and a vein graft
- Aged 50 - 80 years
- Elective or urgent indication for surgery
- Technical possibility of implantation, both a seam-free as well as a conventional prosthesis
- Approval of the study after the enlightenment
- Consent to participate in a one-year follow-up

Exclusion Criteria

- Pure aortic insufficiency without calcifications
- Less than two target vessels for bypass surgery, or target vessels that appear to be unsuitable for an IMA graft investment
- Indication or explicit patient request for implantation of a mechanical prosthesis
- Indication or explicit patient request for implantation of a catheter-based prosthesis
- EF <30%
- Acute endocarditis
- Renal insufficiency (creatinine 2x ULN or dialysis)
- Hepatic impairment (ALT 2x ULN)
- Emergency intervention
- Not present capacity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Medical benefit for patients, according to<br>- hemodynamics of the aortic valve prosthesis intraoperatively and after the operation<br>- operation times (total operating time, HLM-time, aortic clamping time)<br>- postoperative course<br>- hospital stay<br>- duration of ventilation<br>- length of stay in the ICU<br>- postoperative complications (bleeding amount, blood transfusion, new-onset atrial fibrillation, recent onset AV block, respiratory failure, renal failure, infections)<br>- re-hospitalization <br>- quality of life after 3 and 12 months<br><br>Economic benefit in Ulm, according to<br>-DRG revenue<br>- patient-related actual costs (material resources, personnel) <br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath